This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
2018 British pounds
Bain SC, et al. Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme. Diabetes Therapy : Jan 2019. Available from: URL: http://doi.org/10.1007/s13300-019-00736-6
About this article
Cite this article
Oral semaglutide cost effective for T2DM in UK. PharmacoEcon Outcomes News 844, 27 (2020) doi:10.1007/s40274-020-6490-5